Integrated Filing — IndAS



General information about company

Scrip Code 531599
NSE Symbol FDC
MSEI Symbol NOTLISTED
ISIN INE258B01022
Name of company FDC LIMITED
Type of company Main Board
Class of security Equity
Date of start of financial year 01-04-2026
Date of end of financial year 31-03-2027
Date of board meeting when results were approved 27-10-2026
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 21-10-2026
Description of presentation currency INR
Level of rounding used in financial results Lakhs
Reporting Type Quarterly
Reporting Quarter Second quarter
Nature of report standalone or consolidated Consolidated
Whether results are audited or unaudited for the quarter ended Unaudited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Unaudited
Segment Reporting Single segment
Description of single segment Pharmaceutical
Start date and time of board meeting 27-10-2026   12:30:00
End date and time of board meeting 27-10-2026   15:45:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion



Financial Results Ind-AS

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-07-2026 01-04-2026
B Date of end of reporting period 30-09-2026 30-09-2026
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Consolidated Consolidated
1 Income
Revenue from operations 57,214.00 1,23,983.00
Other income 1,794.00 6,328.00
Total income 59,008.00 1,30,311.00
2 Expenses
(a) Cost of materials consumed 13,994.00 28,444.00
(b) Purchases of stock-in-trade 2,991.00 5,139.00
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade 1,529.00 6,295.00
(d) Employee benefit expense 13,428.00 26,944.00
(e) Finance costs 84.00 167.00
(f) Depreciation, depletion and amortisation expense 1,598.00 3,111.00
(f) Other Expenses
1 Other Expenses 18,843.00 36,200.00
Total other expenses 18,843.00 36,200.00
Total expenses 52,467.00 1,06,300.00
3 Total profit before exceptional items and tax 6,541.00 24,011.00
4 Exceptional items 0.00 0.00
5 Total profit before tax 6,541.00 24,011.00
6 Tax expense
7 Current tax 1,655.00 5,633.00
8 Deferred tax (20.00) 223.00
9 Total tax expenses 1,635.00 5,856.00
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0.00 0.00
11 Net Profit Loss for the period from continuing operations 4,906.00 18,155.00
12 Profit (loss) from discontinued operations before tax 0.00 0.00
13 Tax expense of discontinued operations 0.00 0.00
14 Net profit (loss) from discontinued operation after tax 0.00 0.00
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0.00 0.00
16 Total profit (loss) for period 4,906.00 18,155.00
17 Other comprehensive income net of taxes 96.00 196.00
18 Total Comprehensive Income for the period 5,002.00 18,351.00
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent 5,002.00 18,351.00
Total profit or loss, attributable to non-controlling interests 0.00 0.00
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent 5,002.00 18,351.00
Total comprehensive income for the period attributable to owners of parent non-controlling interests 0.00 0.00
21 Details of equity share capital
Paid-up equity share capital 1,628.00 1,628.00
Face value of equity share capital 1 1
27 Details of debt securities
22 Reserves excluding revaluation reserve
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 3.01 11.15
Diluted earnings (loss) per share from continuing operations 3.01 11.15
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 3.01 11.15
Diluted earnings (loss) per share from continuing and discontinued operations 3.01 11.15
24 Debt equity ratio
25 Debt service coverage ratio
26 Interest service coverage ratio
27 Disclosure of notes on financial results Textual Information(1)



Disclosure of notes on financial results

Textual Information(1) Notes: 1. The above unaudited consolidated financial results which are published in accordance with Regulation 33 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’) for the quarter and six months ended September 30, 2026 have been reviewed by the Audit Committee and approved by the Board of Directors of the Parent Company at their meeting held on October 27, 2026. The Statutory Auditors have carried out a limited review of the above results and have expressed an unmodified review conclusion. 2. The Parent Company recognized a fair value loss of Rs. 232 lakhs under Other Expenses in the quarter ended September 30, 2026 (Rs. 143 lakhs in quarter ended September 30, 2025) in accordance with Ind AS 109 (Financial Instruments). However, for the period ended September 30, 2026, a net fair value gain of Rs. 1,608 lakhs (Rs. 1,905 lakhs for the period ended September 30, 2025) was recorded under Other Income. Due to this treatment, the quarterly numbers may not be directly additive to the year-to-date (YTD) numbers, as fair value changes are recognized based on market conditions prevailing at different reporting dates. 3. During the previous year, the Parent Company recognised an incremental employee benefit obligation of Rs. 2,079 lakhs based on an actuarial valuation in accordance with Ind AS 19 – ‘Employee Benefits‘. The impact was disclosed as an exceptional item in the financial statements for the year ended March 31, 2026, considering its non-recurring nature arising from a regulatory change. The Parent Company continues to monitor further notifications and clarifications issued by the Government and will account for any consequential impact, if required, in the period of such developments. 4. The Board of directors, at its meeting held on October 27, 2026 have approved a proposal of the Company to buy-back its 24,00,000 fully paid-up equity shares at a price of Rs. 500 per equity shares from all the eligible equity shareholders of the Company on proportionate basis through the Tender offer route in accordance with SEBI (Buy-Back of securities) Regulation, 2018. 5. The Group has only one segment of activity namely “Pharmaceuticals”. 6. The above results are also available on the website of the Parent Company i.e. www.fdcindia.com and on the website of the Stock Exchanges i.e. www.nseindia.com and www.bseindia.com.



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-04-2026
Date of end of reporting period 30-09-2026
Whether results are audited or unaudited Unaudited
Nature of report standalone or consolidated Consolidated
Assets
1 Non-current assets
Property, plant and equipment 1,03,374.00
Capital work-in-progress 16,339.00
Investment property
Goodwill 0.00
Other intangible assets 513.00
Intangible assets under development 0.00
Biological assets other than bearer plants
Investments accounted for using equity method
Non-current financial assets
Non-current investments 62,962.00
Trade receivables, non-current
Loans, non-current 37.00
Other non-current financial assets
1 Other financial assets 2,669.00
Total of other non-current financial assets 2,669.00
Total non-current financial assets 65,668.00
Deferred tax assets (net)
Other non-current assets
1 Other non-current assets 11,976.00
Total of other non-current assets 11,976.00
Total non-current assets 1,97,870.00
2 Current assets
Inventories 30,176.00
Current financial asset
Current investments 57,485.00
Trade receivables, current 15,362.00
Cash and cash equivalents 3,621.00
Bank balance other than cash and cash equivalents 1,102.00
Loans, current 89.00
Other current financial assets
Total of other current financial assets 853.00
Total current financial assets 78,512.00
Current tax assets (net)
Other current assets
1 Other current assets 11,011.00
Total of other current assets 11,011.00
Total current assets 1,19,699.00
3 Non-current assets classified as held for sale
4 Regulatory deferral account debit balances and related deferred tax Assets
Total assets 3,17,569.00
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 1,628.00
Other equity 2,65,263.00
Total equity attributable to owners of parent 2,66,891.00
Non controlling interest
Total equity 2,66,891.00
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 0.00
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises
Total Trade payable
Other non-current financial liabilities
Total of other non-current financial liabilities
Total non-current financial liabilities 0.00
Provisions, non-current 3,195.00
Deferred tax liabilities (net) 3,263.00
Deferred government grants, Non-current
Other non-current liabilities
1 Other non-current liabilities 853.00
Total of other non-current liabilities 853.00
Total non-current liabilities 7,311.00
Current liabilities
Current financial liabilities
Borrowings, current 0.00
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 2,178.00
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 22,889.00
Total Trade payable 25,067.00
Other current financial liabilities
1 Other current financial liabilities 11,264.00
Total of other current financial liabilities 11,264.00
Total current financial liabilities 36,331.00
Other current liabilities 1,199.00
1 Other current liabilities 1,199.00
Total of other current liabilities 1,199.00
Provisions, current 3,644.00
Current tax liabilities (Net) 2,193.00
Deferred government grants, Current
Total current liabilities 43,367.00
3 Liabilities directly associated with assets in disposal group classified as held for sale
4 Regulatory deferral account credit balances and related deferred tax liability
Total liabilities 50,678.00
Total equity and liabilites 3,17,569.00
Disclosure of notes on assets and liabilities



Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results

Amount in (Lakhs)

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-07-2026 01-04-2026
Date of end of reporting period 30-09-2026 30-09-2026
Whether results are audited or unaudited Unaudited Unaudited
Nature of report standalone or consolidated Consolidated Consolidated
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets null null
Net Segment Asset null null
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities null null
Net Segment Liabilities null null
Disclosure of notes on segments



Other Comprehensive Income

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-07-2026 01-04-2026
B Date of end of reporting period 30-09-2026 30-09-2026
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Consolidated Consolidated
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Amount of items that will not be reclassified to profit and loss 7.00 24.00
Total Amount of items that will not be reclassified to profit and loss 7.00 24.00
2 Income tax relating to items that will not be reclassified to profit or loss 0.00 2.00
3 Amount of items that will be reclassified to profit and loss
Total Amount of items that will be reclassified to profit and loss
4 Income tax relating to items that will be reclassified to profit or loss (89.00) (174.00)
5 Total Other comprehensive income 96.00 196.00



Cash flow statement, indirect

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 01-04-2026
B Date of end of reporting period 30-09-2026
C Whether results are audited or unaudited Unaudited
D Nature of report standalone or consolidated Consolidated
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 24,011.00
Adjustments for reconcile profit (loss)
Adjustments for finance costs 167.00
Adjustments for decrease (increase) in inventories 5,333.00
Adjustments for decrease (increase) in trade receivables, current (279.00)
Adjustments for decrease (increase) in trade receivables, non-current 0.00
Adjustments for decrease (increase) in other current assets (1,767.00)
Adjustments for decrease (increase) in other non-current assets 0.00
Adjustments for other financial assets, non-current 0.00
Adjustments for other financial assets, current (2,021.00)
Adjustments for other bank balances 0.00
Adjustments for increase (decrease) in trade payables, current 4,542.00
Adjustments for increase (decrease) in trade payables, non-current 0.00
Adjustments for increase (decrease) in other current liabilities 816.00
Adjustments for increase (decrease) in other non-current liabilities 0.00
Adjustments for depreciation and amortisation expense 3,111.00
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0.00
Adjustments for provisions, current 0.00
Adjustments for provisions, non-current 0.00
Adjustments for other financial liabilities, current 0.00
Adjustments for other financial liabilities, non-current 0.00
Adjustments for unrealised foreign exchange losses gains 72.00
Adjustments for dividend income 0.00
Adjustments for interest income 0.00
Adjustments for share-based payments 0.00
Adjustments for fair value losses (gains) (1,608.00)
Adjustments for undistributed profits of associates 0.00
Other adjustments for which cash effects are investing or financing cash flow 324.00
Other adjustments to reconcile profit (loss) 39.00
Other adjustments for non-cash items 0.00
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0.00
Total adjustments for reconcile profit (loss) 8,729.00
Net cash flows from (used in) operations 32,740.00
Dividends received 0.00
Interest paid 0.00
Interest received (3,855.00)
Income taxes paid (refund) 3,759.00
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) operating activities 25,126.00
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0.00
Cash flows used in obtaining control of subsidiaries or other businesses 0.00
Other cash receipts from sales of equity or debt instruments of other entities 0.00
Other cash payments to acquire equity or debt instruments of other entities 0.00
Other cash receipts from sales of interests in joint ventures 0.00
Other cash payments to acquire interests in joint ventures 0.00
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0.00
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0.00
Proceeds from sales of property, plant and equipment 208.00
Purchase of property, plant and equipment 15,533.00
Proceeds from sales of investment property 0.00
Purchase of investment property 0.00
Proceeds from sales of intangible assets 0.00
Purchase of intangible assets 0.00
Proceeds from sales of intangible assets under development 0.00
Purchase of intangible assets under development 0.00
Proceeds from sales of goodwill 0.00
Purchase of goodwill 0.00
Proceeds from biological assets other than bearer plants 0.00
Purchase of biological assets other than bearer plants 0.00
Proceeds from government grants 0.00
Proceeds from sales of other long-term assets 46,703.00
Purchase of other long-term assets 61,494.00
Cash advances and loans made to other parties 0.00
Cash receipts from repayment of advances and loans made to other parties 0.00
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0.00
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0.00
Dividends received 0.00
Interest received 4,001.00
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash 178.00
Net cash flows from (used in) investing activities (25,937.00)
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0.00
Payments from changes in ownership interests in subsidiaries 0.00
Proceeds from issuing shares 0.00
Proceeds from issuing other equity instruments 0.00
Payments to acquire or redeem entity's shares 0.00
Payments of other equity instruments 0.00
Proceeds from exercise of stock options 0.00
Proceeds from issuing debentures notes bonds etc 0.00
Proceeds from borrowings 0.00
Repayments of borrowings 0.00
Payments of lease liabilities 332.00
Dividends paid 5.00
Interest paid 0.00
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash (99.00)
Net cash flows from (used in) financing activities (436.00)
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes (1,247.00)
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 0.00
Net increase (decrease) in cash and cash equivalents (1,247.00)
Cash and cash equivalents cash flow statement at beginning of period 4,868.00
Cash and cash equivalents cash flow statement at end of period 3,621.00





Details of Impact of Audit Qualification

Amount in (Lakhs)

Whether results are audited or unaudited Unaudited
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Auditor's opinion
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results Yes
Sr No. Audit firm's name Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI Certificate valid upto
1 BSR & Co LLP Yes 31-07-2028